Cannara Biotech Inc (LOVE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2020 | 08-2019 | 08-2018 | |
| Cash Flows From Operating Activities | |||
| Depreciation Amortization | 2,583 | 566 | 110 |
| Accounts receivable | 472 | -243 | -585 |
| Other Working Capital | -290 | 255 | 392 |
| Other Operating Activity | -12,090 | -7,987 | -1,069 |
| Operating Cash Flow | $-9,325 | $-7,409 | $-1,152 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -8,679 | -22,038 | -14,992 |
| Purchase Sale Intangibles | -134 | -281 | 0 |
| Other Investing Activity | 262 | 680 | 0 |
| Investing Cash Flow | $-8,551 | $-21,640 | $-14,992 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 6,000 | 0 | 12,550 |
| Debt Repayment | -6,563 | -235 | 0 |
| Common Stock Issued | N/A | 46,230 | 17,666 |
| Other Financing Activity | -352 | -3,334 | -1,171 |
| Financing Cash Flow | $-915 | $42,661 | $29,044 |
| Exchange Rate Effect | 56 | -16 | 0 |
| Beginning Cash Position | 26,506 | 12,900 | 0 |
| End Cash Position | 7,771 | 26,506 | 12,900 |
| Net Cash Flow | $-18,790 | $13,612 | $12,900 |
| Free Cash Flow | |||
| Operating Cash Flow | -9,325 | -7,409 | -1,152 |
| Capital Expenditure | -9,315 | -23,294 | -14,992 |
| Free Cash Flow | -18,640 | -30,703 | -16,145 |